Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.

GRDN

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.61B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Guardian Pharmacy Services, Inc.Guardian Pharmacy Services, Inc.39.2-26%1.8-
$49.75

Target Price by Analysts

21.8% upsideGuardian Pharmacy Services Target Price DetailsTarget Price
$53.91

Current Fair Value

32% upside

Undervalued by 32% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.61 Billion
Enterprise Value$2.53 Billion
Dividend Yield$- (-)
Earnings per Share$0.79
Beta0.1
Outstanding Shares63,327,000

Return

Return on Equity25.58%ROE
Return on Assets14.86%
Return on Invested Capital38.16%

Valuation & Multiples

P/E Ratio39.25P/E Ratio
PEG27.6PEG
Price to Sales1.78Price to Sales
Price to Book Ratio10.21Price to Book Ratio
Enterprise Value to Revenue1.73
Enterprise Value to EBIT22.87
Enterprise Value to Net Income38
Total Debt to Enterprise0
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 17, 2026
EPS Estimate
$0.26
Average shareholder expectation
Revenue Estimate
$340.44 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 9, 2026
EPS Estimate
$0.32
Average shareholder expectation
Revenue Estimate
$365.76 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio3.5392▲ 353.92%
Total Calls10,200▲ Infinity%
Total Puts36,100▲ 446.97%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %46.72%▲ 2.00%
Total Invested$1.24B▲ 16.13%
Investors Holding195▲ 23.00%

ESG Score

No data

About Guardian Pharmacy Services, Inc.

3,400 employees
CEO: Mr. Fred P. Burke

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug ...